Vigil Neuroscience, Inc.
VIGL
$1.54
-$0.13-7.78%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.47% | 6.04% | -5.22% | -0.73% | -20.15% |
| Total Depreciation and Amortization | 0.00% | 3.64% | 1.80% | 73.85% | 438.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16.27% | 30.06% | 35.78% | 23.40% | 77.31% |
| Change in Net Operating Assets | -13.60% | 1,839.44% | 8.26% | -0.49% | 947.54% |
| Cash from Operations | -16.96% | 124.84% | -0.97% | 1.37% | 9.23% |
| Capital Expenditure | 100.00% | 100.00% | 95.90% | -- | 95.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -26.62% | -207.92% | 104.77% | 124.03% | -- |
| Cash from Investing | -26.53% | -208.25% | 104.72% | 123.86% | 4,017.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | 8,269.81% | -7.27% | -98.47% | 2,322.43% | -54.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8,269.81% | 37,373.58% | -98.45% | 2,453.69% | -47.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.39% | 489.52% | 60.82% | 99.75% | 72.18% |
